Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;80(1-2):96–103. doi: 10.1038/sj.bjc.6690327

Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice

Y Honma 1, Y Yamamoto-Yamaguchi 1, Y Kanatani 1
PMCID: PMC2363000  PMID: 10389984

Abstract

Vesnarinone, an oral cardiotonic, inhibited the growth of several human non-small cell lung carcinoma cell lines, and its anti-proliferative effects in vitro and in vivo were greatly enhanced by combination with glucocorticoids, but not other steroids. Simultaneous treatment with vesnarinone and dexamethasone is the most effective to evoke the synergistic effect in the growth inhibition of lung carcinoma EBC-1 cells. Dexamethasone and other glucocorticoids induced morphological changes in EBC-1 cells and these agents together with vesnarinone induced alkaline phosphatase activity, which is a typical marker of type II pneumocyte maturation. This treatment arrested the growth of the cells at the G1 phase, indicating that this treatment is cytostatic rather than cytotoxic. These results suggest that vesnarinone plus glucocorticoid might be useful in lung cancer therapy. © 1999 Cancer Research Campaign

Keywords: vesnarinone, glucocorticoid, lung carcinoma, xenograft, differentiation

Full Text

The Full Text of this article is available as a PDF (189.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberts A. S., Thorburn A. M., Shenolikar S., Mumby M. C., Feramisco J. R. Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):388–392. doi: 10.1073/pnas.90.2.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beattie C. W., Hansen N. W., Thomas P. A. Steroid receptors in human lung cancer. Cancer Res. 1985 Sep;45(9):4206–4214. [PubMed] [Google Scholar]
  3. Chakrabarty S., Fan D., Varani J. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. Int J Cancer. 1990 Sep 15;46(3):493–499. doi: 10.1002/ijc.2910460328. [DOI] [PubMed] [Google Scholar]
  4. Chaudhuri P. K., Thomas P. A., Walker M. J., Briele H. A., Das Gupta T. K., Beattie C. W. Steroid receptors in human lung cancer cytosols. Cancer Lett. 1982 Sep;16(3):327–332. doi: 10.1016/0304-3835(82)90014-3. [DOI] [PubMed] [Google Scholar]
  5. Christoffersen J., Smeland E. B., Stokke T., Taskén K., Andersson K. B., Blomhoff H. K. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Cancer Res. 1994 Apr 15;54(8):2245–2250. [PubMed] [Google Scholar]
  6. DeLemos R. A., Shermeta D. W., Knelson J. H., Kotas R., Avery M. E. Acceleration of appearance of pulmonary surfactant in the fetal lamb by administration of corticosteroids. Am Rev Respir Dis. 1970 Sep;102(3):459–461. doi: 10.1164/arrd.1970.102.3.459. [DOI] [PubMed] [Google Scholar]
  7. Dou Q. P., An B., Will P. L. Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9019–9023. doi: 10.1073/pnas.92.20.9019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edelson J. D., Shannon J. M., Mason R. J. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis. 1988 Nov;138(5):1268–1275. doi: 10.1164/ajrccm/138.5.1268. [DOI] [PubMed] [Google Scholar]
  9. Goto I., Hozumi M., Honma Y. Selective effect of O-alkyl lysophospholipids on the growth of a human lung giant cell carcinoma cell line. Anticancer Res. 1994 Mar-Apr;14(2A):357–362. [PubMed] [Google Scholar]
  10. Goto I., Yamamoto-Yamaguchi Y., Honma Y. Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents. Br J Cancer. 1996 Aug;74(4):546–554. doi: 10.1038/bjc.1996.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hartwell L. H., Kastan M. B. Cell cycle control and cancer. Science. 1994 Dec 16;266(5192):1821–1828. doi: 10.1126/science.7997877. [DOI] [PubMed] [Google Scholar]
  12. Hofmann J., Kaiser U., Maasberg M., Havemann K. Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. Eur J Cancer. 1995 Nov;31A(12):2053–2058. doi: 10.1016/0959-8049(95)00431-9. [DOI] [PubMed] [Google Scholar]
  13. Jones K. L., Anderson N. S., 3rd, Addison J. Glucocorticoid-induced growth inhibition of cells from a human lung alveolar cell carcinoma. Cancer Res. 1978 Jun;38(6):1688–1693. [PubMed] [Google Scholar]
  14. Kanatani Y., Kasukabe T., Hozumi M., Motoyoshi K., Nagata N., Honma Y. Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line. Leuk Res. 1993 Oct;17(10):847–853. doi: 10.1016/0145-2126(93)90150-j. [DOI] [PubMed] [Google Scholar]
  15. Kanatani Y., Kasukabe T., Okabe-Kado J., Hayashi S., Yamamoto-Yamaguchi Y., Motoyoshi K., Nagata N., Honma Y. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth Differ. 1996 Feb;7(2):187–196. [PubMed] [Google Scholar]
  16. Karp J. E., Broder S. Molecular foundations of cancer: new targets for intervention. Nat Med. 1995 Apr;1(4):309–320. doi: 10.1038/nm0495-309. [DOI] [PubMed] [Google Scholar]
  17. Kikkawa Y., Kaibara M., Motoyama E. K., Orzalesi M. M., Cook C. D. Morphologic development of fetal rabbit lung and its acceleration with cortisol. Am J Pathol. 1971 Aug;64(2):423–442. [PMC free article] [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Liggins G. C., Howie R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972 Oct;50(4):515–525. [PubMed] [Google Scholar]
  20. Liggins G. C. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol. 1969 Dec;45(4):515–523. doi: 10.1677/joe.0.0450515. [DOI] [PubMed] [Google Scholar]
  21. Ludlow J. W., Glendening C. L., Livingston D. M., DeCarprio J. A. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol. 1993 Jan;13(1):367–372. doi: 10.1128/mcb.13.1.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marchetti A., Doglioni C., Barbareschi M., Buttitta F., Pellegrini S., Bertacca G., Chella A., Merlo G., Angeletti C. A., Dalla Palma P. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene. 1996 Mar 21;12(6):1319–1324. [PubMed] [Google Scholar]
  23. Mattern J., Klinga K., Runnebaum B., Volm M. Influence of hormone therapy on human lung tumors transplanted into nude mice. Oncology. 1985;42(6):388–390. doi: 10.1159/000226069. [DOI] [PubMed] [Google Scholar]
  24. McCormick C., Freshney R. I., Speirs V. Activity of interferon alpha, interleukin 6 and insulin in the regulation of differentiation in A549 alveolar carcinoma cells. Br J Cancer. 1995 Feb;71(2):232–239. doi: 10.1038/bjc.1995.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McLean J. S., Frame M. C., Freshney R. I., Vaughan P. F., Mackie A. E., Singer I. Phenotypic modification of human glioma and non-small cell lung carcinoma by glucocorticoids and other agents. Anticancer Res. 1986 Sep-Oct;6(5):1101–1106. [PubMed] [Google Scholar]
  26. Miyamoto G., Sasabe H. Pharmacokinetics of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey. Arzneimittelforschung. 1984;34(3A):394–402. [PubMed] [Google Scholar]
  27. Sato M., Harada K., Bando T., Shirakami T., Nakashiro K., Yoshida H., Nakai S., Kawai K., Adachi M. Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice. Cancer Lett. 1995 May 4;91(1):1–9. doi: 10.1016/0304-3835(95)03713-7. [DOI] [PubMed] [Google Scholar]
  28. Sato S., Tomoyasu S., Okabe-Kado J., Hozumi M., Tsuruoka N., Nakai S., Adachi M., Honma Y. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent. Exp Hematol. 1996 Jan;24(1):37–42. [PubMed] [Google Scholar]
  29. Schroy P., Rifkin J., Coffey R. J., Winawer S., Friedman E. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res. 1990 Jan 15;50(2):261–265. [PubMed] [Google Scholar]
  30. Twardzik D. R., Ranchalis J. E., McPherson J. M., Ogawa Y., Gentry L., Purchio A., Plata E., Todaro G. J. Inhibition and promotion of differentiated-like phenotype of a human lung carcinoma in athymic mice by natural and recombinant forms of transforming growth factor-beta. J Natl Cancer Inst. 1989 Aug 2;81(15):1182–1185. doi: 10.1093/jnci/81.15.1182. [DOI] [PubMed] [Google Scholar]
  31. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 1995 May 5;81(3):323–330. doi: 10.1016/0092-8674(95)90385-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES